Peptides for skin: creams, supplements, and injection claims

01 · Continued

“Peptides for skin” can mean several different products.: more detail

Evidence belongs to the exact ingredient and finished product. It also belongs to the route, which means how the product enters the body. The people, comparison group, and measured result matter too. A skin-cream result does not prove a whole-body effect from an injection. A collagen study does not prove that a copper-peptide serum works. Approval of one medicine does not approve a tanning product with a similar claim.

This guide separates skin cosmetics, collagen supplements, the approved afamelanotide medicine, and unapproved or research-labeled injections. It does not rank brands, choose a route, or recommend self-treatment.

02

Topical peptide skincare is a finished product.

Skin-care labels can list copper tripeptide-1, palmitoyl tripeptide-1, palmitoyl pentapeptide-4, acetyl hexapeptide-8, or other peptides. These are different ingredients. They are not versions of one standard “peptide complex.” Products can also differ in strength, stability, other ingredients, package, and how much reaches the skin.

A study of one serum cannot show what each ingredient did. It also cannot prove that another formula works because both labels name one shared ingredient. A study might test a mixture against its base formula or use a machine to measure the skin. It might last only a few weeks. A change can be small, uncertain, or limited to that product and setting.

FDA generally does not approve cosmetics before sale. Color additives are an important exception. The company that makes a cosmetic is still responsible for safety and honest labels.

FDA also separates cosmetic and drug claims. Moisturizing skin or making lines look less clear through added moisture can be a cosmetic claim. A promise to remove wrinkles or increase collagen changes the body's structure or function. Under U.S. law, that promise can make the product a drug.

“Cosmetic” is a legal category. It does not prove that a formula works or has no risks.

03

What topical peptide studies can and cannot show.

Some studies put people into skin-treatment groups by chance. This type of study is called randomized. Some report changes in wrinkles, roughness, moisture, stretch, or people's ratings. A systematic review uses a planned method to find and check all relevant studies.

One recent review included 19 randomized studies. Seventeen tested products taken by mouth, and only two tested products used on the skin. Most positive combined results came from the oral studies. Evidence for skin products was sparse. The review makes the topic worth studying, but it does not give every peptide cream the same effect.

The studies tested different peptides, mixed formulas, delivery methods, comparison products, measures, and study lengths. Some treated one side of each person's face differently from the other side. This can reduce differences between people, but the result still belongs to the tested product.

A product can contain peptides with vitamin C, hyaluronic acid, or other active ingredients. Such a study cannot show which part caused a change. A result in cells or skin tissue outside the body also does not prove a visible benefit in people.

The review found few unwanted events in the included studies. Yet short studies of selected products cannot rule out rare harms or harms that take a long time to appear. A safety result for one cream does not apply to an untested formula or an injection.

Some peptide skin products have positive results from studies in people. The size, length, repeat testing, usefulness, and safety follow-up of those results differ. The word “peptides” on a label cannot prove an anti-aging, collagen, wound-healing, skin-repair, or long-term safety claim for the whole group.

04

GHK-Cu: the human skin result is limited.

GHK-Cu is the short peptide glycyl-L-histidyl-L-lysine joined to copper. A cosmetic label may call it copper tripeptide-1. Lab work gives researchers a reason to study it. Lab work does not show a skin benefit in people. The clearest study in this review tested a GHK-Cu skin product after carbon-dioxide laser treatment.

Only 13 people finished the study. The study did not show a statistically significant difference between groups in how quickly redness improved. Computer measures and reviewers who did not know which treatment each person used also found no clear difference in wrinkles or overall skin quality. People using GHK-Cu gave higher ratings for overall skin quality on a questionnaire.

The study shows that one GHK-Cu skin-care regimen was tested in people. It does not prove a better wrinkle result, routine wound treatment, or a broad anti-aging effect.

The setting matters too. Skin healing after laser treatment is not the same as uninjured skin using an everyday serum. The study product and comparison do not represent every “copper peptide” product. The study gives no evidence that injected GHK-Cu improves skin or causes safe repair throughout the body. An injection claim needs its own study of that exact product and route.

05

Collagen peptides are oral supplements, not skin creams.

“Collagen peptides” usually means hydrolyzed collagen sold as a powder, capsule, drink, or another supplement. Hydrolyzed means broken into smaller pieces. It is a group of products, not one exact drug. The source, peptide size, serving contents, other ingredients, and quality controls can differ. Its evidence is separate from the evidence for a skin serum.

A 2025 review combined 23 randomized trials with 1,474 people. When all trials were combined, collagen supplements appeared to improve skin moisture, stretch, and wrinkles.

The result changed when the authors checked study quality and funding. Studies without funding from pharmaceutical companies did not show improvement. Higher-quality studies also did not show a clear benefit. The positive skin-stretch result came from lower-quality studies. The authors concluded that current evidence did not support collagen supplements to prevent or treat skin aging.

This review does not prove that every collagen product has no effect. It shows that an all-study headline can make the evidence look stronger than it is. It also cannot show that two powders are equal.

FDA does not approve dietary supplements before sale. It also does not usually approve their claims or test each product before sale. A Supplement Facts panel shows that the item is sold as a supplement. A required claim disclaimer does not mean that FDA found the skin claim effective.

06

Afamelanotide is an approved rare-disease medicine, not cosmetic skincare.

Afamelanotide can affect skin color, but its approved product has a narrow medical use. FDA approved the Scenesse implant for adults with erythropoietic protoporphyria (EPP). EPP is a rare condition in which light can cause painful skin reactions. The implant can increase pain-free light exposure in adults with this condition and a history of those reactions.

This approval belongs to the exact implant, use, patient group, and professional care setting. Scenesse is not an approved cosmetic tanning implant or anti-aging treatment.

The label calls for skin checks. It says that existing moles and freckles may darken. It also tells patients to keep using sun and light protection. The approved result does not show that darker skin makes ultraviolet exposure safe.

Scenesse is not the same as a cream, injected GHK-Cu, melanotan II, or an online product called “melanotan.” A shared link to skin color does not make two molecules or products equal.

The accurate statement is narrow: Scenesse is approved to increase pain-free light exposure in a defined group of adults with EPP. This does not approve peptides as a class for skin. It does not prove a cosmetic benefit for another product.

07

Injected and research-labeled skin products need separate safety evidence.

An injection puts a product into the body in a different way. It needs different manufacturing controls and separate safety evidence.

FDA's compounding-risk page says GHK-Cu was nominated for injection, then withdrawn from review. FDA also says that human safety data are limited. It notes possible immune reactions linked to peptide clumps and unwanted peptide material. These concerns apply to injection. They do not show that every skin cream has the same risk. They do show why cream results cannot validate an injection.

In general, a molecule name or lab certificate cannot show that a vial matches a study product. It does not prove the same sequence, chemical form, purity, sterility, strength, stability, or other ingredients. No human outcome study found for this guide shows that injected GHK-Cu improves skin or reverses aging. The reviewed evidence does not confirm a safe and effective injectable “skin peptide” group.

Melanotan II is a different molecule and product from afamelanotide. Scenesse approval does not prove that melanotan II is safe, effective, well made, or protective against sunlight. FDA says compounded melanotan II may pose immune risks from peptide clumps or unwanted material.

FDA also notes case reports involving melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome, and priapism. Posterior reversible encephalopathy syndrome is a serious brain condition. Sympathomimetic toxidrome is a toxic reaction that can overstimulate the body. Priapism is a long and painful erection.

Case reports cannot show how common an event is or prove that a product caused it. They are warning signals. This guide gives no injection, purchase, preparation, dosing, or product-selection instructions.

08

How to check a peptide skincare claim.

Sales pages often combine an ingredient, a possible body effect, a study, and a product into one promise. Separate these parts.

First, identify the product type: skin cosmetic, oral supplement, approved medicine, compounded drug, or research-labeled product. Write down the exact ingredient and finished product. A private “peptide blend” may not say what is in the product. A familiar brand term may name a mixture, not one molecule.

Next, turn the promise into a result that can be measured. “Supports youthful skin” does not say whether the study checked wrinkles, moisture, stretch, redness, healing, skin color, or people's ratings.

Look for a controlled study in people of the same product, route, patient group, result, and time period. Check for other active ingredients. Check what the study used for comparison. Also check how many people finished, whether reviewers knew which product was used, and who paid for the study.

Finally, compare the sales claim with the actual result. A cell study about collagen does not prove fewer wrinkles. Higher ratings on a survey do not prove a change in skin structure. A registered trial is not a posted result. “Dermatologist tested” does not say what was tested or whether it worked.

Weak evidence does not prove that a product cannot help. It means that the advertised benefit is not confirmed at that level.

• Name the exact ingredient, formulation, and route.
• Match the advertised benefit to the result that the study measured.
• Check the study size, length, comparison, reviewer knowledge, and funding.
• Do not transfer a result between topical, oral, implanted, and injected products.
• Treat regulatory status and evidence strength as separate questions.

09

Bottom line: match the claim to the product and study.

There is no single “best peptide for skin” supported by evidence for the whole group. Some exact skin formulas have positive results in people. Those results have important limits. The small GHK-Cu study after laser treatment found no clear objective improvement over its comparison product.

Oral collagen results become less certain when study quality and funding are considered. Afamelanotide has an approved product for a rare condition. It is not approved for cosmetic tanning or general skin repair. Injection claims do not inherit evidence from creams, supplements, or Scenesse.

Ask whether the exact product and advertised result match a controlled study in people. A high peptide count, a strong before-and-after claim, a familiar name, or a “research grade” label cannot answer that question.

A changing skin spot, a severe reaction, an infection, or symptoms after an unknown injection need medical care. A qualified clinician can assess the person and the exact product. This guide cannot diagnose a condition, verify an online product, or replace personal care.